Study Group: Cethromycin Experts(?)
Council Members in this Study Group: 21
Request a survey with this Study Group
Leading Experts in this Study Group
Dept. Chair of Medicine at WellSpan Healthcare
York Hospital
Paul Iannini, MD, is the Chairman of the Department of Medicine and Executive Director of Medical Services for WellSpan Healthcare at York Hospital in York, Pennsylvania. He is also Clinical Professor of Medicine at Milton S. Hershey School of Medicine in Hershey, PA. He has expertise in anti-infective...
Joseph Bertino, Pharm.D.Independent Consultant
Bertino Consulting
Joseph Bertino, PharmD, is an Associate Professor of Pharmacology at Columbia University College of Physicians and Surgeons in New York. Through Bertino Consulting, he consults to the pharmaceutical industry in areas of infectious diseases, drug metabolism, and clinical pharmacology. Dr. Bertino's research...
Related Study Groups
GLG NewsSMAnalyses by this Study Group's Leading Experts(?)
1. Radioimmunoassay is very hard to proof the basic biology of metastatic patient. 2. GVAX Immunotherapy is basically modify the GM-CSF, so the exact biology of immune system of the patient should be considered in metastatic stage before use. As the tumor is already...
1. The phase II clinical trial of the combination thherapy of ( temozolomide and Thalidomide for Malignant Melanoma is very encourganing. It may open new avenue to treat malignant melanoma affecting Brain. 2. This article is important for use of combination...
1. Merck and GSK are pushing too much for Cerival cancer vaccine advertisement. 2. Merck ( Gardasil), and GSK( cervarix) are very tiny age applications, but real disease start after 20, so early vaccination is no use, but Pap smear is more helpful 3. So drug marker push to cancer vaccine lead...
1. BiovaxID® is a personalized, patient-specific therapeutic vaccine designed to stimulate the patient's own immune system to recognize and destroy cancerous B-cells that may remain in the body or may arise after the patient has been treated with chemotherapy. 2. Unlike many other approaches...
1. As Byetta is not monotherapy and the clinical trial results are not clear about the condition od trial patient, so future of Byetta is blink
Most Common Company Types:
- Academic Medical Center/Hospital or Clinic
- Consultancy, Pharma-Focused
- Office Based Private Practice or Clinic
- Pharmaceuticals Manufacturer
- Academic Institution*
- Consultancy, Healthcare-Focused
- Contract Research Organization, Independent/Small
- Contract Research Organization, Large
Most Common Job Types:
- Physician - Attending Physician
- Physician - Director
- President
- Owner
- Research & Development Manager
- Physician - Department Chair
- Director
- Research Scientist
- Chief Executive Officer
- Consultant
- Manager
- Physician - Division Head
- Professor
GLG's 750+ Clients Include:
global mutual funds
global banks
private equity firms